Diabetes and oral contraception. Lipoprotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives;DIABETESREGULERING OG P-PILLER. LIPOPROTEINOMSAETNING HOS KVINDER MED INSULINKRAEVENDE DIABETES MELLITUS I P-PILLEBEHANDLING

Ugeskrift for Laeger

Volumn 158, Issue 17, 1996, Pages 2388-2392

  Petersen, Kresten Rubeck ^a   Skouby, Sven Olaf ^b   Jepsen, Pernille Vedel ^b   Haaber, Anne Birgitte ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GESTODENE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CLINICAL ARTICLE; HORMONAL CONTRACEPTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN METABOLISM; ORAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; DIABETES MELLITUS, TYPE 1; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; HUMANS; LIPOPROTEINS; NORPREGNENES; PROSPECTIVE STUDIES;

EID: 0029927912     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hanson U, Persson B, Thunell S. Relation between hemoglobin Ale in early type 1 (insulin dependent) diabetic pregnancy and the occurrence of spontaneous abortions and fetal malformation in Sweden. Diabetologia 1990; 33: 100-4.
2. Mills JI, Simpson JL, Driscoll SG, Jovanovic-Peterson L, van Alien M, Aarous JH et al. Incidence of spontaneous abortion among normal women and insulin dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319: 1617-23.
3. Kjer K. Hagen C, Sandø SH. Eshøj O. Contraception in women with IDDM. An epidemiological study. Diabetes Care 1992; 15: 585-90.
4. Steel JM, Duncan LJP. Serious complications of oral contraceptives in insulin dependent diabetes. Contraception 1978; 17: 291-5.
5. Radberg T, Gustafson A, Skryten A, Karlsson K. Oral contraception in diabetic women. Diabetes control and high density lipoprotein lipids during low dosage progestogen, combined oestrogen/progestogen and non-hormonal contraception. Acta Endocrinol 1981; 98: 246-51.
6. Petersen KR, Skouby SO, Pedersen RG. Desogestrel and gestodene in oral contraceptives: 12 months assessment of glucose- and lipoprotein metabolism. Obstet Gynecol 1991; 78: 666-72.
7. Dolhofer R, Weiss L, Wieland OH. Experience with the glucose-dehydrogenase-UV-method for the determination of blood glucose. J Clin Chem Clin Biochem 1976; 14: 415-7.
8. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC. Plasma lipid and coagulation factor concentration in insulin dependent diabetics with microalbuminuria. BMJ 1989; 298: 487-90.
9. Freimann JA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error and sample size in the design and Interpretation of the randomized control trial. N Engl J Med 1978; 299: 690-4.
10. Steel JM, Duncan LJP. The effects of oral contraceptives on insulin requirement in diabetics. Br J Fam Plann 1978; 3: 77-8.
11. Taskinen MB. Quantitavite and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41 (suppl 2): 12-7.
12. La Rosa JC. The varying effects of progestins on lipid levels and cardiovascular disease. Am J Obstet Gynecol 1988; 158: 1621-9.
13. Gevers Leuven JA, Dersjant-Roorda MC, Helmerhorst FM. de Boer R, Neymeyer-Leloux A, Havecs I. Estogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism. Am J Obstet Gynecol 1990; 163: 358-62.
14. Fioretti P, Fruzzetti F. Navalesi R, Ricci C, Miccoli R, Cerri M et al. Clinical and metabolic study of a new pill containing 20 meg ethinyl estradiol plus 0.150 mg desogestrel. Contraception 1987; 35: 229-43.
15. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Non enzymatic glycosylation of low-density lipoprotein alters its biological activity. Diabetes 1982; 31: 283-91.
16. Haarbo J, Leth-Espesen P. Stender S. Christiansen C. Estogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectornized cholesterol-fed rabbits. J Clin Invest 1991; 87: 1274-9.
17. Gay EC. Cai Y, Gale SM, Baron A, Cruickshanks KJ, Kostraba JN et al. Smokers with IDDM experience excess morbidity. The Colorado IDDM Registry. Diabetes Care 1992; 15: 947-52.
18. Microalbuminuria Collaborative Study Group. Risk factors for development of microalbuminuria in insulin dependent diabetic patients. BMJ 1993: 306: 1235-9.
19. Dullaart KP, Groener JE, Dikkeschei BD. Erkelens DW, Doorenbos H. Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. Diabetes Care 1991; 14: 338-41.
20. Scheffler E. Wiest E, Woehrle J, Otto I, Schulz I. Huber L et al. Smoking influences the atherogenic potential of low-density protein. Clin Invest 1992; 70: 263-8.